AKESOgen

AKESOgen is an integrated genomics, genetics and biobanking company that services the pharmaceutical, biotechnology, clinical, academic, and government sectors for clinical trials, diagnostic clinical testing and research. Based in greater Atlanta, GA, the company’s initial focus has been oncology and personalized medicine. AKESOgen’s Research Services and Clinical/Regulatory Services include providing high-throughput biomarker profiling, cytogenomic arrays, sequencing (both NGS and Sanger), genotyping and epigenomic analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, and methylation) to CLIA/GLP standards. Their expertise in genomics and process control as well as their customer commitment make AKESOgen an ideal partner to execute and deliver on your projects.

AKESOgen headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical sector. The company focuses on Biotechnology and has secured $111.0M in funding across 60 round(s). With a team of 11-50 employees, AKESOgen is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - AKESOgen, raised $50.0K. Discover more about their projects, partnerships, and impact on our platform.